U.S. federal trademark · Serial No. 85280475 · Reg. No. 4045133
Research, discovery and development of targeted therapeutics for the treatment of genetically-defined cancer patients, namely, small molecule histone methyltransferase (HMT) inhibitors
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.